Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of High Dose CoQ10 in ALS

NCT00243932 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00243932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of High Dose CoQ10 in ALS
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2005
Completion date
March 31, 2008
Enrollment
185 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, lou gehrig's disease